Padma has 15+ years of experience leading and transforming organizations with disruptive diagnostic technologies to revenue stage companies with market leading tests. She has successfully launched multiple diagnostics globally, as kits and CLIA services, driving test inclusion as standard-of-care with expertise in oncology and transplant monitoring markets. Prior to joining ChromaCode, Padma held key leadership roles at Affymetrix, Roche, Guardant Health, CellMax Life, and Oncocyte.
Clinical Dx Showcase:
ChromaCode’s HDPCR technology enables any laboratory in the world the ability to offer high-value diagnostics for Oncology Dx, MRD, Blood-based Monitoring, NIPT, and Infectious Disease.
HDPCR: Empowering High-Value Diagnostics for All Labs
Empowering high-value diagnostics for all labs in Oncology, MRD, Blood-based Monitoring, NIPT, and Infectious Disease.
The PMWC 2023 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.